Ranjan Bhattacharyya

Dr. Ranjan Bhattacharyya

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Indian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
RBRanjan Bhattacharyya
Ranjan Bhattacharyya
SCSeshadri Sekhar Chatterjee
Seshadri Sekhar Chatterjee
SBSumita Bhattacharyya
Sumita Bhattacharyya
SGSukanya Gupta
Sukanya Gupta
Soumitra DasSoumitra Das
Soumitra Das
BBBejoy Bikram Banerjee
Bejoy Bikram Banerjee
Background: COVID-19, like every other pandemic, has imposed an unprecedented threat to doctors' physical and mental health. Literature in this area is sparse. The present study has been done to explore the knowledge, attitude, and behavior of doctors regarding this pandemic and how it influences their depression, anxiety, and stress level. Materials and Methods: This online survey has been done for 10 days. Data were collected on background characteristics, knowledge, attitude, and behavior of the respondents in a semi-structured pro forma, and psychiatric morbidity was measured by the Depression, Anxiety, and Stress Scale-21. A total of 152 complete responses have been received. The data were assessed using SPSS software. Results: Out of 152 study participants, 34.9% were depressed and 39.5% and 32.9% were having anxiety and stress, respectively. Significant predictors for psychiatric morbidities were experience in health sector, duty hours, use of protective measures, and altruistic coping. Multivariable logistic regression showed most of the factors to be significantly associated with depression, anxiety, and stress level. Discussion: Doctors who were working during COVID pandemic have a high prevalence of psychiatric morbidity. Age and having multiple comorbidities are significant predictive factors. Adequate protective measures should be warranted. Altruistic coping and a sense of greater goal are significant among the doctor community, in this pressing time. The doctors are pushing themselves to the best of their capacity and also protecting their patients' best interest. A large-scale, multicentric study will probably give a larger picture and will guide us for better service planning and delivery.

1 January 2023 in Journal of SAARC Psychiatric Federation
Verified
Journal Article
Open access
RBRanjan Bhattacharyya
Ranjan Bhattacharyya
KCKaustav Chakraborty
Kaustav Chakraborty
RNRjarshi Neogi
Rjarshi Neogi
Chat generative pretrained transformer (ChatGPT) was designed by American start-up OpenAI designed in 2015, since its formal introduction on December 6, 2022 it had 1 million users in just more than a month and has become a hot topic of discussion. It will be interesting to find through research work whether ChatGPT can provide us with a comprehensive search and supersedes its earlier competitors such as Google Assistant, Alexa, and Siri. It was beyond wild imagination to everyone how the conversational robot was capable of understanding questions and answering them with superb accuracy. The application of ChatGPT in the field of medical sciences is intriguing and promises to open a new arena. As other systems of communication, Chatbot should be applied in medical sciences maintaining ethical concerns and remembering that, at times, ChatGPT can give inaccurate and wrong answers.

22 March 2022 in Indian Journal of Psychiatry
Verified
Journal Article
Open access
PGPrasad Rao Gundugurti
Prasad Rao Gundugurti
RBRanjan Bhattacharyya
Ranjan Bhattacharyya
SKSandeep Kondepi
Sandeep Kondepi
KCKaustav Chakraborty
Kaustav Chakraborty
AMAbir Mukherjee
Abir Mukherjee

23 March 2022 in Indian Journal of Psychiatry
Verified
Journal Article
Open access
RBRanjan Bhattacharyya
Ranjan Bhattacharyya
AGAnirban Gozi
Anirban Gozi
ASAratrika Sen
Aratrika Sen

1 January 2020 in Indian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
RBRanjan Bhattacharyya
Ranjan Bhattacharyya
SCSeshadri Sekhar Chatterjee
Seshadri Sekhar Chatterjee
SBSumita Bhattacharyya
Sumita Bhattacharyya
SGSukanya Gupta
Sukanya Gupta
Soumitra DasSoumitra Das
Soumitra Das
BBBejoy Bikram Banerjee
Bejoy Bikram Banerjee
Indian J Psychiatry, Indian Journal of Psychiatry is the official publication of the Indian Psychiatric Society that considers for publication articles in all fields of Psychiatry

1 July 2022 in D Y Patil Journal of Health Sciences
Verified
Journal Article
Open access
RBRanjan Bhattacharyya
Ranjan Bhattacharyya
Cariprazine is a partial agonist of dopamine and serotonin with high affinity for D3 receptor. There is excess endogenous dopamine both in schizophrenia and bipolar disorder. Cariprazine binds to D3/D2 receptor as antagonist and agonist in schizophrenia and bipolar depression, respectively. Thus, the dopamine pathway inhibited and stimulated in the respective cases. The United States Food and Drug Administration (USFDA) approval now covers the full-spectrum Bipolar I disorder, yet to hit the Indian market.